GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized

Product Details
Customization: Available
Application: Digestive System
Usage Mode: IV
Gold Member Since 2024

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
In-stock Capacity
The supplier has In-stock capacity
100% Finished Products Inspection
The supplier inspects 100% of finished products.
to see all verified strength labels (17)
  • GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
  • GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
  • GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
  • GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
  • GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
  • GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
Find Similar Products

Basic Info.

Model NO.
30mg
Suitable for
Adult
State
Liquid
Shape
Small-Volume Injection
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
SL2022001
Drug Ad Approval No.
SL2022001
Test Repot
Available
Period of Validity
3 Years
Authentication
GMP
Register Dossier
Available
Quality Standard
Bp or USP
Customized
According to Your Requirement
Appearance
Powder
Transport Package
Carton Box
Specification
30mg
Trademark
shenglu
Origin
Shandong China
HS Code
3001909099
Production Capacity
1 Billion /Year

Product Description

GMP manufacturer Lansoprazole for Injection 30mg human medicine support customized 
Molecular Formula 369.36
CAS No. 103577-45-3
Delivery Items Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
  4°C 2 years
In solvent -80°C 6 months
  -20°C 1 month

Lansoprazole is firstly transferred to the acid-producing region of the gastric mucosal parietal cells, and transformed into an activated form through conversion reaction by acid. This reaction product is considered to combine with the SH-groups of (H + , K + )-ATPase which is locally located in the acid-producing region and playing a role of the proton pump, suppressing the enzyme activity to inhibit the acid secretion. It has been reported that blood coagulation and platelet aggregation capacities are severely impaired under acidic conditions, and that fibrin formed as a result of blood coagulation is dissolved by pepsin under acidic conditions. Lansoprazole is considered to increase gastric pH, thereby improving blood coagulation and platelet aggregation capacities and inhibiting peptic activity, resulting in suppression of bleeding. Also, lansoprazole is considered to increase gastric pH by inhibiting acid secretion, thereby promoting repair of injured mucosa, which is inhibited under acidic conditions.

Details of photoes 
GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized






GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
OTHER  STOMACH MEDICINES 
GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support CustomizedGMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized
GMP Manufacturer Lansoprazole for Injection 30mg Human Medicine Support Customized


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier